Posts Tagged: colorectal cancer
Updates in GI Cancers with Dr. Axel Grothey
Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »
Dr. Grothey on the Role of Precision Medicine in CRC
Axel Grothey, MD, medical oncologist and our Director of Gastrointestinal Cancer Research, discusses the role of precision medicine in colorectal cancer (CRC) with OncLive. Grothey says, “With the rise of molecular profiling, the field of CRC has shifted away from a one-size-fits-all approach and entered an era of precision medicine. Notably, molecular profiling guides the… Read more »
Grothey Published in NEJM for Colorectal Cancer Care
Axel Grothey, MD The New England Journal of Medicine (NEJM) has recently published an editorial entitled “Pembrolizumab as first-line therapy in mismatch repair-deficient advanced colorectal cancer: A new standard of care” written by West Cancer Center’s GI Medical Oncology Lead and GI Oncology Clinical Research Director, Dr. Axel Grothey. Click the link below… Read more »